Aligos Therapeutics ALGS SEC Filings

NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Aligos Therapeutics, Inc. (ALGS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-450798Nov 6, 2026 1:07 PM
28-KCurrent Report0001171843-26-007214Nov 6, 2026 1:00 PM
38-KCurrent Report0001193125-26-391880Sep 15, 2026 8:03 PM
4S-8Prospectus0001193125-26-337937Aug 6, 2026 8:04 PM
510-QQuarterly & Annual Report0001193125-26-336851Aug 6, 2026 12:07 PM
68-KCurrent Report0001171843-26-005294Aug 6, 2026 12:00 PM
74Insider Transaction0001610717-26-000305Jun 29, 2026 8:38 PM
84Insider Transaction0001610717-26-000304Jun 29, 2026 8:37 PM
94Insider Transaction0001610717-26-000303Jun 29, 2026 8:37 PM
104Insider Transaction0001610717-26-000302Jun 29, 2026 8:36 PM
114Insider Transaction0001610717-26-000301Jun 29, 2026 8:36 PM
124Insider Transaction0001610717-26-000300Jun 29, 2026 8:35 PM
138-KCurrent Report0001193125-26-285426Jun 26, 2026 8:02 PM
14SCHEDULE 13DBeneficial Ownership Report0001193125-26-281134Jun 24, 2026 8:30 PM
15SCHEDULE 13GBeneficial Ownership Report0001193125-26-226938May 15, 2026 8:30 PM
16SCHEDULE 13GBeneficial Ownership Report0000919574-26-003231May 15, 2026 1:05 PM
1710-QQuarterly & Annual Report0001193125-26-212001May 7, 2026 8:18 PM
188-KCurrent Report0001171843-26-003156May 7, 2026 8:08 PM
19DEFA14AOthers0001193125-26-191940Apr 29, 2026 8:33 PM
20ARSOthers0001193125-26-191897Apr 29, 2026 8:29 PM
21DEF 14AOthers0001193125-26-191843Apr 29, 2026 8:25 PM
228-KCurrent Report0001193125-26-166987Apr 21, 2026 8:32 PM
238-KCurrent Report0001193125-26-154927Apr 14, 2026 8:17 PM
244Insider Transaction0001610717-26-000095Mar 11, 2026 8:19 PM
254Insider Transaction0001610717-26-000094Mar 11, 2026 8:14 PM
264Insider Transaction0001610717-26-000093Mar 11, 2026 8:13 PM
274Insider Transaction0001610717-26-000092Mar 11, 2026 8:13 PM
28S-8Prospectus0001193125-26-092647Mar 5, 2026 1:28 PM
2910-KQuarterly & Annual Report0001193125-26-092614Mar 5, 2026 1:08 PM
308-KCurrent Report0001171843-26-001340Mar 5, 2026 1:01 PM
313Insider Transaction0001610717-26-000055Feb 19, 2026 10:54 PM
32SCHEDULE 13GBeneficial Ownership Report0000902664-26-001065Feb 17, 2026 8:22 PM
33SCHEDULE 13GBeneficial Ownership Report0001214659-26-001502Feb 11, 2026 9:32 PM
348-KCurrent Report0001193125-26-037558Feb 4, 2026 9:05 PM
35SCHEDULE 13GBeneficial Ownership Report0000902664-25-005026Nov 14, 2025 9:15 PM
3610-QQuarterly & Annual Report0001193125-25-268203Nov 6, 2025 1:37 PM
378-KCurrent Report0001171843-25-007075Nov 6, 2025 1:30 PM
38SCHEDULE 13GBeneficial Ownership Report0000902664-25-003590Aug 14, 2025 3:54 PM
39SCHEDULE 13GBeneficial Ownership Report0001214659-25-011951Aug 13, 2025 6:00 PM
40SCHEDULE 13GBeneficial Ownership Report0000902664-25-003496Aug 12, 2025 1:00 PM
41S-8Prospectus0001193125-25-174519Aug 6, 2025 8:36 PM
4210-QQuarterly & Annual Report0000950170-25-104042Aug 6, 2025 8:13 PM
438-KCurrent Report0001171843-25-005116Aug 6, 2025 8:06 PM
444Insider Transaction0001610717-25-000290Jul 18, 2025 9:14 PM
454Insider Transaction0001610717-25-000289Jul 18, 2025 9:14 PM
464Insider Transaction0001610717-25-000286Jul 18, 2025 8:41 PM
474Insider Transaction0001610717-25-000259Jun 26, 2025 8:31 PM
484Insider Transaction0001610717-25-000258Jun 26, 2025 8:30 PM
494Insider Transaction0001610717-25-000257Jun 26, 2025 8:30 PM
504Insider Transaction0001610717-25-000256Jun 26, 2025 8:30 PM
...

Aligos Therapeutics, Inc. SEC Filings API

Pull Aligos Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ALGS&formtype=10-K,10-Q&api_key=YOUR_API_KEY